Cargando…
Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681071/ https://www.ncbi.nlm.nih.gov/pubmed/33249247 http://dx.doi.org/10.1016/j.thromres.2020.11.020 |
_version_ | 1783612560370565120 |
---|---|
author | Qin, Wei Dong, Fen Zhang, Zhu Hu, Bingzhu Chen, Shi Zhu, Ziyang Li, Fajiu Wang, Xiaojiang Zhang, Yunxia Wang, Yimin Zhen, Kaiyuan Wang, Jing Elalamy, Ismaïl Li, Chenghong Zhai, Zhenguo Davidson, Bruce L. Wang, Chen |
author_facet | Qin, Wei Dong, Fen Zhang, Zhu Hu, Bingzhu Chen, Shi Zhu, Ziyang Li, Fajiu Wang, Xiaojiang Zhang, Yunxia Wang, Yimin Zhen, Kaiyuan Wang, Jing Elalamy, Ismaïl Li, Chenghong Zhai, Zhenguo Davidson, Bruce L. Wang, Chen |
author_sort | Qin, Wei |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7681071 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76810712020-11-23 Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era Qin, Wei Dong, Fen Zhang, Zhu Hu, Bingzhu Chen, Shi Zhu, Ziyang Li, Fajiu Wang, Xiaojiang Zhang, Yunxia Wang, Yimin Zhen, Kaiyuan Wang, Jing Elalamy, Ismaïl Li, Chenghong Zhai, Zhenguo Davidson, Bruce L. Wang, Chen Thromb Res Letter to the Editors-in-Chief Elsevier Ltd. 2021-02 2020-11-23 /pmc/articles/PMC7681071/ /pubmed/33249247 http://dx.doi.org/10.1016/j.thromres.2020.11.020 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editors-in-Chief Qin, Wei Dong, Fen Zhang, Zhu Hu, Bingzhu Chen, Shi Zhu, Ziyang Li, Fajiu Wang, Xiaojiang Zhang, Yunxia Wang, Yimin Zhen, Kaiyuan Wang, Jing Elalamy, Ismaïl Li, Chenghong Zhai, Zhenguo Davidson, Bruce L. Wang, Chen Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era |
title | Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era |
title_full | Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era |
title_fullStr | Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era |
title_full_unstemmed | Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era |
title_short | Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era |
title_sort | low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: a cohort study in the early epidemic era |
topic | Letter to the Editors-in-Chief |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681071/ https://www.ncbi.nlm.nih.gov/pubmed/33249247 http://dx.doi.org/10.1016/j.thromres.2020.11.020 |
work_keys_str_mv | AT qinwei lowmolecularweightheparinand28daymortalityamongpatientswithcoronavirusdisease2019acohortstudyintheearlyepidemicera AT dongfen lowmolecularweightheparinand28daymortalityamongpatientswithcoronavirusdisease2019acohortstudyintheearlyepidemicera AT zhangzhu lowmolecularweightheparinand28daymortalityamongpatientswithcoronavirusdisease2019acohortstudyintheearlyepidemicera AT hubingzhu lowmolecularweightheparinand28daymortalityamongpatientswithcoronavirusdisease2019acohortstudyintheearlyepidemicera AT chenshi lowmolecularweightheparinand28daymortalityamongpatientswithcoronavirusdisease2019acohortstudyintheearlyepidemicera AT zhuziyang lowmolecularweightheparinand28daymortalityamongpatientswithcoronavirusdisease2019acohortstudyintheearlyepidemicera AT lifajiu lowmolecularweightheparinand28daymortalityamongpatientswithcoronavirusdisease2019acohortstudyintheearlyepidemicera AT wangxiaojiang lowmolecularweightheparinand28daymortalityamongpatientswithcoronavirusdisease2019acohortstudyintheearlyepidemicera AT zhangyunxia lowmolecularweightheparinand28daymortalityamongpatientswithcoronavirusdisease2019acohortstudyintheearlyepidemicera AT wangyimin lowmolecularweightheparinand28daymortalityamongpatientswithcoronavirusdisease2019acohortstudyintheearlyepidemicera AT zhenkaiyuan lowmolecularweightheparinand28daymortalityamongpatientswithcoronavirusdisease2019acohortstudyintheearlyepidemicera AT wangjing lowmolecularweightheparinand28daymortalityamongpatientswithcoronavirusdisease2019acohortstudyintheearlyepidemicera AT elalamyismail lowmolecularweightheparinand28daymortalityamongpatientswithcoronavirusdisease2019acohortstudyintheearlyepidemicera AT lichenghong lowmolecularweightheparinand28daymortalityamongpatientswithcoronavirusdisease2019acohortstudyintheearlyepidemicera AT zhaizhenguo lowmolecularweightheparinand28daymortalityamongpatientswithcoronavirusdisease2019acohortstudyintheearlyepidemicera AT davidsonbrucel lowmolecularweightheparinand28daymortalityamongpatientswithcoronavirusdisease2019acohortstudyintheearlyepidemicera AT wangchen lowmolecularweightheparinand28daymortalityamongpatientswithcoronavirusdisease2019acohortstudyintheearlyepidemicera |